Title

Acute Cough Study In Children
A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Single-Dose, Pilot Study To Evaluate Efficacy Of Dextromethorphan Hydrobromide On Acute Cough In A Pediatric Population
  • Phase

    Phase 4
  • Study Type

    Interventional
  • Study Participants

    140
15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6 hours.
In light of protocol changes required due to methodological and operational issues, including background noise in cough recordings which could impact data interpretation, the study has been terminated.
Study Started
Dec 31
2010
Primary Completion
Mar 31
2011
Study Completion
Mar 31
2011
Results Posted
Sep 20
2012
Estimate
Last Update
Sep 20
2012
Estimate

Drug Dextromethorphan

A single 10 mL dose of Children's Triaminic Syrup (Dextromethorphan Hydrobromide 7.5 mg per 5 mL (total dose of 15 mg)

Drug Placebo

A single 10 mL dose of matching placebo syrup

Active Experimental

Placebo Placebo Comparator

Criteria

Inclusion Criteria:

Male or female healthy children ages 6 to under 12 years who are symptomatic with a cough due to a cold or acute URTI characterized by:

Onset of cold/URTI symptoms occurring no more than 10 days prior to Visit 1;
At least 5 coughs during the second 30-minute period of the 60-minute baseline period.

General good health, aside from a common cold, and has no contraindications to the study or rescue medication

Exclusion Criteria:

Acute, subchronic, or chronic cough due to any other condition other than a common cold

History of clinically significant cardiovascular, pulmonary, hepatic, renal, neurological, hematological, autoimmune, psychiatric, metabolic, gastro-intestinal or endocrine disease

Summary

Placebo

Dextromethorphan Hydrobromide

All Events

Event Type Organ System Event Term Placebo Dextromethorphan Hydrobromide

Total Cough Count

Total cough count was done by trained assessors using continuous digital video and audio recordings.

Placebo

238.7
Cough counts (Mean)
Standard Deviation: 252.3

Dextromethorphan Hydrobromide

190.9
Cough counts (Mean)
Standard Deviation: 190.6

Change From Baseline in Perceived Verbal Cough Severity Scale for 6 Hour Post-Dose Period

Perceived verbal cough severity score was assessed on a 5-point categorical rating scale in accordance to the question "How much have you coughed in the last hour?", where 0 = not at all, 1 = a tiny bit, 2 = a little, 3 = some and 4 = a lot. The change from baseline over the 6-hour post-dosing period calculated as the average of change from baseline [that is (i.e.) baseline value minus the post baseline value] measurements of Hour 1 to Hour 6, thus the change from baseline ranged from -4 to 4; higher score indicated a better improvement.

Placebo

Baseline

3.0
Units on a scale (Mean)
Standard Deviation: 0.9

Change for 6 hour post-dose period

1.3
Units on a scale (Mean)
Standard Deviation: 1.1

Dextromethorphan Hydrobromide

Baseline

2.9
Units on a scale (Mean)
Standard Deviation: 0.9

Change for 6 hour post-dose period

1.1
Units on a scale (Mean)
Standard Deviation: 1.1

Change From Baseline in Verbal Cough Severity Scale at Hours 1, 2, 3, 4, 5 and 6

Verbal cough severity score was assessed on a 5-point categorical rating scale in accordance to the question "How much have you coughed in the last hour?", where 0 = not at all, 1 = a tiny bit, 2 = a little, 3 = some and 4 = a lot. The change from baseline values were derived by subtracting each post baseline value from the baseline value, and ranged from -4 to 4; higher score indicated a better improvement.

Placebo

Change at 1 hour

1.0
Units on a scale (Mean)
Standard Deviation: 1.2

Change at 2 hours

1.2
Units on a scale (Mean)
Standard Deviation: 1.2

Change at 3 hours

1.3
Units on a scale (Mean)
Standard Deviation: 1.2

Change at 4 hours

1.4
Units on a scale (Mean)
Standard Deviation: 1.3

Change at 5 hours

1.7
Units on a scale (Mean)
Standard Deviation: 1.3

Change at 6 hours

1.5
Units on a scale (Mean)
Standard Deviation: 1.4

Dextromethorphan Hydrobromide

Change at 1 hour

0.9
Units on a scale (Mean)
Standard Deviation: 1.2

Change at 2 hours

0.9
Units on a scale (Mean)
Standard Deviation: 1.4

Change at 3 hours

0.9
Units on a scale (Mean)
Standard Deviation: 1.4

Change at 4 hours

1.1
Units on a scale (Mean)
Standard Deviation: 1.4

Change at 5 hours

1.2
Units on a scale (Mean)
Standard Deviation: 1.4

Change at 6 hours

1.2
Units on a scale (Mean)
Standard Deviation: 1.4

Change From Baseline in Perceived Numerical Cough Severity Scale for 6 Hour Post-Dose Period

Perceived numerical cough severity score was assessed on an 11-point categorical rating scale in accordance to the question "How much have you coughed in the last hour?", where 0 = did not cough at all and 10 = cough a lot. The change from baseline for the 6-hour post-dosing period was calculated as the average of change from baseline (i.e. baseline value minus the post baseline value) measurements of Hour 1 to Hour 6, thus the change from baseline values ranged from -10 to 10; higher score indicated a better improvement.

Placebo

Baseline

6.8
Units on a scale (Mean)
Standard Deviation: 2.2

Change for 6 hour post-dose period

2.8
Units on a scale (Mean)
Standard Deviation: 2.5

Dextromethorphan Hydrobromide

Baseline

7.0
Units on a scale (Mean)
Standard Deviation: 2.3

Change for 6 hour post-dose period

2.5
Units on a scale (Mean)
Standard Deviation: 3.1

Change From Baseline in Numerical Cough Severity Scale at Hours 1, 2, 3, 4, 5 and 6

Numerical cough severity score was assessed on an 11-point categorical rating scale in accordance to the question "How much have you coughed in the last hour?", wherein 0 = did not cough at all and 10 = cough a lot. The change from baseline was derived by subtracting the post baseline value from the baseline value and ranged from -10 to 10; higher score indicated a better improvement.

Placebo

Change at 1 hour

2.0
Units on a scale (Mean)
Standard Deviation: 2.9

Change at 2 hours

2.5
Units on a scale (Mean)
Standard Deviation: 2.6

Change at 3 hours

2.7
Units on a scale (Mean)
Standard Deviation: 2.7

Change at 4 hours

2.9
Units on a scale (Mean)
Standard Deviation: 2.8

Change at 5 hours

3.6
Units on a scale (Mean)
Standard Deviation: 2.8

Change at 6 hours

3.4
Units on a scale (Mean)
Standard Deviation: 3.3

Dextromethorphan Hydrobromide

Change at 1 hour

2.0
Units on a scale (Mean)
Standard Deviation: 2.8

Change at 2 hours

2.1
Units on a scale (Mean)
Standard Deviation: 3.5

Change at 3 hours

2.3
Units on a scale (Mean)
Standard Deviation: 3.5

Change at 4 hours

2.5
Units on a scale (Mean)
Standard Deviation: 3.6

Change at 5 hours

3.0
Units on a scale (Mean)
Standard Deviation: 3.2

Change at 6 hours

2.8
Units on a scale (Mean)
Standard Deviation: 3.8

Participants' Global Assessment of Cough: Cough Severity

Participant global assessment of cough with the assistance of parent or legal guardian was scored on a 5-point categorical scale based on response to the question " How much have you coughed in the past 6 hours?" where 0 = not at all, 1 = a tiny bit, 2 = a little, 3 = some and 4 = a lot.

Placebo

3.1
Units on a scale (Mean)
Standard Deviation: 0.9

Dextromethorphan Hydrobromide

3.0
Units on a scale (Mean)
Standard Deviation: 1.3

Participants' Global Assessment of Cough: Relief From Cough

Participant global assessment of cough with the assistance of parent or legal guardian was scored on a 5-point categorical scale based on response to the question "From when you woke up this morning until now, how much better is your cough?" where 0 = not at all better, 1 = a tiny bit better, 2 = a little better, 3 = better and 4 = a lot better.

Placebo

2.9
Units on a scale (Mean)
Standard Deviation: 1.0

Dextromethorphan Hydrobromide

2.7
Units on a scale (Mean)
Standard Deviation: 1.3

Total

107
Participants

Age Continuous

8.9
Years (Mean)
Standard Deviation: 1.7

Sex: Female, Male

Overall Study

Placebo

Dextromethorphan Hydrobromide

Drop/Withdrawal Reasons

Placebo

Dextromethorphan Hydrobromide